Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a...
Equity mutual funds generated strong returns last week, with international funds dominating the performance chart. Mirae Asset Global X Artificial Intelligence & Technology ETF FoF emerged...
Revolution Medicines reports phase 3 pancreatic cancer trial results
This article was written by Follow I am an avid investor with a major focus on small cap companies with experience in investing in US, Canadian,...
Wordle enthusiasts logging into The New York Times’ popular daily word game on Sunday encountered a musical challenge as the answer for puzzle No. 1807 was...
This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at analyzing...
This article was written by Follow Scott Kaufman, aka Treading Softly, learned about investing firsthand from over a decade of financial sector experience. He is the...
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive...
The unlisted shares of Zepto Limited have fallen nearly 30% over the past month despite the company securing regulatory approval for its IPO, highlighting growing caution...
Experimental Novartis radiopharma drug shows promise in early study